NCT02171793View on ClinicalTrials.gov

Single Rising Peroral Doses of BI 1744 CL in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2007

Conditions
Healthy
Interventions
DRUG

BI 1744 CL

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02171793 - Single Rising Peroral Doses of BI 1744 CL in Healthy Volunteers | Biotech Hunter | Biotech Hunter